NEOTIL
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

NEOTIL Trademark

Serial Number: 97255807 • Registration: 7910611

NEOTIL is a trademark filed by Ludwig Institute for Cancer Research Ltd. on February 7, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Ludwig Institute for Cancer Research Ltd. (7 trademarks)

Zürich 8001 , CH

Entity Type: 99

Trademark Details

Filing Date

February 7, 2022

Registration Date

August 26, 2025

Published for Opposition

June 10, 2025

Goods & Services

Biomanufacturing for others, namely, manufacturing of pharmaceuticals using biological organisms in the manufacturing process

Pharmaceutical preparations for use in cell therapy for the treatment of cancer; Pharmaceutical preparations for use in chemotherapy, immunology, and oncology; biological preparations for the identification and treatment of cancer and oncological conditions; Cells for medical use, namely, cells for use in creating cell therapies for the treatment of medical conditions

Cells for scientific, laboratory or medical research

Providing medical services in the nature of adoptive cell therapy; Stem cell therapy services; Personalized stem cell therapy services for the treatment of cancer; Stem cell therapy services and treatments containing cells, and lymphocytes for medical and clinical use

laboratory research in the field of drug discovery, cell therapy, stem cells, microorganisms, human tissues, biological and biotechnological substances and biomanufacturing; Development and test of chemical production methods for pharmaceuticals; Pharmaceutical research and development; biotechnological services, namely, biotechnological analysis and research services in the field of cellular therapeutics

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 26, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 26, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 10, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jun 10, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 4, 2025 NONP
CASE RETURNED TO EXAMINATION
Nov 29, 2024 OTHE
NOTICE OF ALLOWANCE CANCELLED
Nov 29, 2024 IUCN
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 29, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 3, 2024 NPUB
PUBLISHED FOR OPPOSITION
Sep 3, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 14, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 29, 2024 CNSA
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jan 29, 2024 RCSC
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jan 10, 2024 RCCK
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Aug 29, 2023 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 30, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
May 30, 2023 GNSL
SUSPENSION LETTER WRITTEN
May 30, 2023 CNSL
EXAMINER'S AMENDMENT ENTERED
May 25, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 25, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
May 25, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 25, 2023 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 9, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 9, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 9, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 19, 2022 GNRN
NON-FINAL ACTION E-MAILED
Nov 19, 2022 GNRT
NON-FINAL ACTION WRITTEN
Nov 19, 2022 CNRT
ASSIGNED TO EXAMINER
Nov 18, 2022 DOCK
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Mar 2, 2022 AMPX
ASSIGNED TO LIE
Mar 1, 2022 ALIE
TEAS VOLUNTARY AMENDMENT RECEIVED
Feb 26, 2022 PARI
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 11, 2022 NWOS
NEW APPLICATION ENTERED
Feb 10, 2022 NWAP